Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Face validity of the sickle cell disease health-related stigma scale in youth with sickle cell disease
source: The Journal of Pain
year: 2017
authors: E. Wakefield, C. Jenerette, J. Santanelli, W. Zempsky
summary/abstract:Stigma research is limited among youth with sickle cell disease (SCD). There is support for health-related stigma among adults with SCD. Part of the challenge of stigma research in youth with SCD is the limited availability of assessment tools to evaluate this construct. The purpose of the current study is to evaluate face validity among youth with SCD of the Sickle Cell Disease Health Related Stigma Scale (SCD-HRSS), which has been validated among young adults with SCD. Feedback from adolescents and young adults with SCD will inform modifications to the SCD-HRSS for youth. The SCD-HRSS is a 30-item questionnaire evaluating perception of stigma among the three existing domains: general public, physicians and family members. An additional 10 items were included to develop a nurse domain. 12 youth with SCD (M = 18.77, SD = 2.27) were recruited from both inpatient and outpatient settings. The participants were asked to rate each of the 40 SCD-HRSS items on a 5-point Likert scale regarding level of importance to their illness experience. Our findings suggest that 90.05% of items demonstrate consistent face validity, with four items identified as having inconsistent importance across two subscales: family (N =3) and nurses (N = 1). Of note, there were no problematic items identified within the general public and physician subscales. Overall, SCD-HRSS demonstrates face validity for a majority of items. The ability to understand the role of stigma for youth with SCD is dependent on the ability to reliably and accurately measure stigma. Face validity is the first step in the validation process. Future research implications include the further establishment of psychometric properties for the SCD-HRSS.
organization: Connecticut Children's Medical Center, Hartford, CTDOI: 10.1016/j.jpain.2017.02.158
read more
Related Content
-
Marc Stuart Zumberg, MDDr. Zumberg is recognized as an outstand...
-
Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemiaSilent cerebral infarction (SCI) is the ...
-
SCDAI’S 19th Annual Golf OutingIn 2021, we are celebrating 50 years as ...
-
Nancy Green, MDNancy Green, MD is a pediatric hematolog...
-
Children’s National Health SystemSickle cell disease affects many familie...
-
Dr. Wayne A. I. Frederick launches ‘Run to Cure Sickle Cell’ campaignDr. Wayne A. I. Frederick today announce...
-
Indiana Sickle Cell Disease Conference by The Martin CenterThis one day 2018 Indiana Sickle Cell Di...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.